Agilent Determination of LSD, iso-LSD, and 2-Oxo-3-Hydroxy-LSD in Urine Using the HP1100 LC/MSD

安捷伦 的其他说明书

• Agilent Technologies Impact of Ion-Pair Reagents on LC/MS Analysis
• Agilent The Effect of Nonvolatile Buffers on the HP 1100 Series LC/MSD
• Agilent Technologies Coupling of nano-LC to MALDI mass spectrometry - Real-time LC run mapping on a MALDI plate
• Agilent Technologies Analysis of beta-blocking drugs on Agilent 1100 Series LC systems using UV, fluorescence and mass spectrometry detection
• Agilent Technologies Determination of Opiates and Metabolites in Blood Using Electrospray LC/MS
• Agilent Technologies Using Software Tools to Improve the Detection of Impurities by LC/MS
• Agilent Technologies Determination of Digoxin in Human Serum by LC/MS with Online Sample Preparation
• Agilent Technologies Rapid Analysis of Drugs of Abuse by LC/Triple Quadrupole Mass Spectrometry
• Agilent Technologies Analysis of a complex natural product extract from ginseng - Part II: Structure elucidation of ginsenosides by high resolution ion trap LC/MS
• Agilent Technologies Identification of red and white blood cells from whole blood samples using the Agilent 2100 bioanalyzer
• Agilent Technologies Separation of Explosives in EPA 8330: Column Choices Optimize Speed, Resolution, and Solvent Use
• Agilent Technologies A Column-Flow Independent Configuration for QuickSwap
• Agilent Technologies Developing a fast, generic method for rapid resolution LC with quadrupole MS detection
• Agilent Technologies Fast LC analysis with quadrupole MS detection – without loss of spectral quality
• Agilent Technologies 21 CFR Part 11 Compliance Features of the LC/MSD Trap Security Pack 1.0 Software

查看 安捷伦 全部说明书 →